Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 2/20 | 0.61 |
| ▸ | NAAA | Q02083 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | DGKA | P23743 | 1/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | RAD52 | P43351 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 6/20 | 0.42 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29467312 | 1.00 | FAAH (0.61) | FAAHNAAAALDH1A1ATMDGKA | |
| SCHEMBL27939809 | 0.98 | FAAH (0.59) | FAAHNAAAALDH1A1ATMDGKA | |
| SCHEMBL10524903 | 0.96 | FAAH (0.58) | FAAHNAAAALDH1A1ATMDGKA | |
| SCHEMBL10603195 | 0.94 | FAAH (0.70) | FAAHNAAAALDH1A1DGKAHTR2C | |
| SCHEMBL10604360 | 0.92 | FAAH (0.73) | FAAHNAAADGKAHTR2CTSHR | |
| SCHEMBL8602516 | 0.92 | FAAH (0.73) | FAAHNAAADGKAHTR2CTSHR | |
| SCHEMBL10604950 | 0.92 | FAAH (0.73) | FAAHNAAADGKAHTR2CTSHR | |
| SCHEMBL10901480 | 0.92 | FAAH (0.73) | FAAHNAAADGKAHTR2CTSHR | |
| SCHEMBL1010990 | 0.91 | FAAH (0.66) | FAAHNAAAALDH1A1ATMDGKA | |
| SCHEMBL6669031 | 0.86 | FAAH (0.50) | FAAHNAAAALDH1A1DGKAHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118638002-A | Preparation method of sodium valproate toxic metabolite 2-propyl-4-pentenoic acid | 湖南大学 | 2024-09-13 | — | — | CN | claimed |
| CN-116947600-B | Preparation method of 2-isopropyl valeric acid as valproic acid process impurity | 湖南省湘中制药有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-116874347-B | Preparation method of impurity dipropylvaleric acid in valproic acid process | 湖南省湘中制药有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-116947600-A | Preparation method of 2-isopropyl valeric acid as valproic acid process impurity | 湖南省湘中制药有限公司 | 2023-10-27 | — | — | CN | claimed |
| CN-116874347-A | Preparation method of impurity dipropylvaleric acid in valproic acid process | 湖南省湘中制药有限公司 | 2023-10-13 | — | — | CN | claimed |
| CN-107876092-B | Application of titanium catalyst with cyclic structure as reaction catalyst for synthesizing benzyl carbonate or diphenyl carbonate by ester exchange | 华东理工大学 | 2023-01-10 | — | — | CN | claimed |
| EP-4069792-A1 | MICHAEL REACTION-CURING HYBRID SYSTEM FOR USE IN CHEMICAL FASTENING TECHNOLOGY | fischerwerke GmbH & Co. KG (DE) | 2022-10-12 | — | — | EP | claimed |
| CN-114729253-A | Michael addition hardening synthetic resin for chemical fixing technology | 费希尔厂有限责任两合公司 | 2022-07-08 | — | — | CN | claimed |
| CN-114729224-A | Michael addition hardening hybrid system for chemical fixation technology | 费希尔厂有限责任两合公司 | 2022-07-08 | — | — | CN | claimed |
| WO-2021110621-A1 | MICHAEL REACTION-CURING HYBRID SYSTEM FOR USE IN CHEMICAL FASTENING TECHNOLOGY | FISCHERWERKE GMBH & CO. KG (DE) | 2021-06-10 | — | — | WO | claimed |
| CN-101657759-B | Alkali-developable photosensitive resin composition and beta-diketone | ADEKA CORP | 2012-07-25 | — | — | CN | claimed |
| CN-114423758-B | Antibacterial compounds | 爱尔兰詹森科学公司 | 2025-05-27 | — | — | CN | disclosed |
| CN-118638002-A | Preparation method of sodium valproate toxic metabolite 2-propyl-4-pentenoic acid | 湖南大学 | 2024-09-13 | — | — | CN | disclosed |
| US-20240199611-A1 | ANTIBACTERIAL COMPOUNDS | Janssen Sciences Ireland Unlimited Company (IE) | 2024-06-20 | — | — | US | disclosed |
| CN-116947600-B | Preparation method of 2-isopropyl valeric acid as valproic acid process impurity | 湖南省湘中制药有限公司 | 2024-04-26 | — | — | CN | disclosed |
| US-4188395-A | 1,4-Dihydropyridine derivatives substituted in the 2 position, and their use as medicaments | BAYER AKTIENGESELLSCHAFT (DE) | 1980-02-12 | — | — | US | disclosed |
| US-4081596-A | DIURETIC, SALURETIC, ANTIHYPERTENSIVE, ANTITHROMBOTIC | BAYER AKTIENGESELLSCHAFT (DT) | 1978-03-28 | — | — | US | disclosed |
| US-4005215-A | DIURETIC | BAYER AKTIENGESELLSCHAFT (DT) | 1977-01-25 | — | — | US | disclosed |
| US-3978077-A | DIURETIC, HYPOTENSIVE, ANTITHROMBOTIC | BAYER AKTIENGESELLSCHAFT (GB) | 1976-08-31 | — | — | US | disclosed |
| US-3957814-A | DIURETICS, SALURETICS, HYPOTENSIVE AGENTS, ANTITHROMBOTIC | BAYER AKTIENGESELLSCHAFT (DT) | 1976-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240199611-A1 | ANTIBACTERIAL COMPOUNDS | FDPS, MT-ND4, NDUFS3 | FAAH 4420/4885NAAA 1056/4885ALDH1A1 1644/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.